The Relationship Between Microbiota and Coronary Ectasia

Konya Beyhekim Training and Research Hospital2 enrolled

Overview

Introduction: It is now known that the microbiota is far beyond the microbial communities living in certain parts of our body and functions like a metabolic organ. In addition, the microbiota, through its metabolites, is involved in the pathophysiology or progression of a wide range of diseases, from atherosclerotic diseases to metabolic diseases and even neurological diseases. Among these metabolites, trimethylamine n-oxide metabolite has been shown to be particularly effective on atherosclerotic heart diseases.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Coronary Ectasia Microbial Disease

Interventions

Taking blood for kit studyDIAGNOSTIC_TEST

Taking blood for kit study (Elisa kit)

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * over 18 years old * not having occlusive coronary artery disease * having coronary ectasia Exclusion Criteria: * patients with chronic kidney disease, * revascularized coronary artery disease, * previously documented critical coronary stenosis, * acute or chronic inflammatory disease, * rheumatologic disease, * known active malignant disease, * heart failure, * moderate-to-severe valvular pathology * patients who were on any steroid or immunosuppressive therapy

Locations (1)

Necmettin Erbakan University

Konya, Turkey (Türkiye)

Outcomes

Primary Outcomes

death

Death from any cause within the last month

Time frame: 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.